Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Jul;66(1):99-105.
doi: 10.1053/j.ajkd.2015.02.323. Epub 2015 Apr 2.

Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study

Affiliations
Comparative Study

Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study

Mathias Haarhaus et al. Am J Kidney Dis. 2015 Jul.

Abstract

Background: Renal osteodystrophy encompasses the bone histologic abnormalities seen in patients with chronic kidney disease (CKD). The bone-specific alkaline phosphatase (bALP) isoform B1x is exclusively found in serum of some patients with CKD.

Study design: The aim of this cross-sectional diagnostic test study was to examine the relationship between serum bALP isoform activity and histomorphometric parameters of bone in patients with CKD receiving maintenance hemodialysis.

Settings & participants: Anterior iliac crest bone biopsy samples from 40 patients with CKD were selected on the basis of bone turnover for histomorphometric analysis. There were samples from 20 patients with low and 20 with non-low bone turnover.

Index test: In serum, bALP, bALP isoforms (B/I, B1x, B1, and B2), and parathyroid hormone (PTH) were measured.

Reference test: Low bone turnover was defined by mineral apposition rate < 0.36μm/d. Non-low bone turnover was defined by mineral apposition rate ≥ 0.36μm/d.

Other measurements: PTH.

Results: B1x was found in 21 patients (53%) who had lower median levels of bALP, 18.6 versus 46.9U/L; B/I, 0.10 versus 0.22 μkat/L; B1, 0.40 versus 0.88 μkat/L; B2, 1.21 versus 2.66 μkat/L; and PTH, 49 versus 287pg/mL, compared with patients without B1x (P<0.001). 13 patients (65%) with low bone turnover and 8 patients (40%) with non-low bone turnover (P<0.2) had detectable B1x. B1x correlated inversely with histomorphometric parameters of bone turnover. Receiver operating characteristic curves showed that B1x can be used for the diagnosis of low bone turnover (area under the curve [AUC], 0.83), whereas bALP (AUC, 0.89) and PTH (AUC, 0.85) are useful for the diagnosis of non-low bone turnover.

Limitations: Small number of study participants. Requirement of high-performance liquid chromatography methods for measurement of B1x.

Conclusions: B1x, PTH, and bALP have similar diagnostic accuracy in distinguishing low from non-low bone turnover. The presence of B1x is diagnostic of low bone turnover, whereas elevated bALP and PTH levels are useful for the diagnosis of non-low bone turnover.

Keywords: B/I, B1x, B1, B2; Bone-specific alkaline phosphatase (bALP); bALP isoforms; bone histology; diagnostic test study; end-stage renal disease (ESRD); hemodialysis; low bone turnover; mineral apposition rate; parathyroid hormone (PTH); renal osteodystrophy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study flow diagram.
Figure 2
Figure 2
ROC curves of (A) B1x for diagnosis of low bone turnover defined by mineral apposition rate < 0.36 µm/d and (B) bALP (—) and PTH (…) for diagnosis of non-low bone turnover defined by mineral apposition rate ≥ 0.36 µm/d.
Figure 2
Figure 2
ROC curves of (A) B1x for diagnosis of low bone turnover defined by mineral apposition rate < 0.36 µm/d and (B) bALP (—) and PTH (…) for diagnosis of non-low bone turnover defined by mineral apposition rate ≥ 0.36 µm/d.

References

    1. Malluche HH, Monier-Faugere MC. Renal osteodystrophy: what's in a name? Presentation of a clinically useful new model to interpret bone histologic findings. Clin. Nephrol. 2006;65(4):235–242. - PubMed
    1. Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int. 2006;69(11):1945–1953. - PubMed
    1. Garrett G, Sardiwal S, Lamb EJ, Goldsmith DJ. PTH--a particularly tricky hormone: why measure it at all in kidney patients? Clin. J. Am. Soc. Nephrol. 2013;8(2):299–312. - PubMed
    1. Herberth J, Monier-Faugere MC, Mawad HW, et al. The five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients. Clin. Nephrol. 2009;72(1):5–14. - PMC - PubMed
    1. Magnusson P, Lofman O, Larsson L. Determination of alkaline phosphatase isoenzymes in serum by high-performance liquid chromatography with post-column reaction detection. J. Chromatogr. 1992;576(1):79–86. - PubMed

Publication types

MeSH terms